Alzheimer’s disease is the leading cause of dementia, impacting millions worldwide. It gradually harms memory, cognitive functions, and the ability to carry out everyday activities.
While researchers have made significant progress understanding the disease, there is still no cure. Current medications only provide symptom relief or temporarily slow progression. Consequently, scientists are exploring new strategies to halt the disease before it spreads throughout the brain.
A recent discovery by researchers at the University of Utah Health offers an intriguing clue. Their research, published in the journal Cell, indicates that a normal brain protein called Arc might unintentionally facilitate the spread of Alzheimer’s from one neuron to another.
One primary factor contributing to Alzheimer’s is the accumulation of a defective protein called Tau. In healthy brain cells, Tau supports the neuron’s internal structure. However, in Alzheimer’s, Tau misfolds and clumps into harmful aggregates that ultimately damage and kill neurons.
As neurons become compromised, these Tau clumps can break down into tiny fragments known as Tau seeds. These seeds can be transferred to nearby healthy neurons, prompting normal Tau proteins to also misfold and form toxic aggregates. This process fuels the disease’s progression into new areas of the brain.
The scientists aimed to understand how Tau moves between neurons. They examined mice with Alzheimer’s-like pathology, comparing those that produced the Arc protein with those that did not. Arc is known to support learning and memory by facilitating neuron-to-neuron communication.
They discovered that Arc incorporates itself into small bubble-like transport vesicles known as extracellular vesicles. These vesicles serve as the brain’s messaging system. Unfortunately, Tau appears to hijack this system by attaching to Arc and hitchhiking inside these vesicles.
Removing Arc significantly reduced Tau transfer between neurons, nearly preventing disease spread. This indicates that Arc plays a vital role in enabling toxic Tau to reach healthy cells.
Interestingly, Arc also serves a protective function. It helps damaged neurons release excess Tau, which decreases intracellular toxic buildup. Without Arc, these neurons accumulate more harmful Tau and are more prone to early death.
This suggests that future therapies should be nuanced. Instead of completely inhibiting Arc, it might be better to block the release of Tau-containing vesicles after they depart damaged neurons, preventing them from infecting healthy ones while still allowing neurons to clear some toxic proteins themselves.
This research offers valuable insight into Alzheimer’s progression, highlighting a biological pathway that could be targeted therapeutically. The strength of the study lies in elucidating mechanisms rather than just describing disease characteristics.
Nevertheless, since the findings were primarily obtained in mice, further research is necessary before translating these results into human treatments. Confirming these mechanisms in humans could pave the way for therapies that slow brain deterioration and help maintain memory capacity longer.
If you’re interested in Alzheimer’s, consider reading about how lifestyle habits influence the risk and how strawberries might serve as a protective factor against the disease.
Additional studies suggest that oral cannabis extract might alleviate some Alzheimer’s symptoms, and vitamin E could potentially help in Parkinson’s prevention.
Source: University of Utah Health.